id: NEW:alcohol_related_liver_disease_progression_to_liver_disease_mortality
name: Alcohol-Related Liver Disease Progression (Steatosis to Cirrhosis) â†’ Liver Disease
  Mortality
from_node:
  node_id: NEW:alcohol_related_liver_disease_progression
  node_name: Alcohol-Related Liver Disease Progression (Steatosis to Cirrhosis)
to_node:
  node_id: liver_disease_mortality
  node_name: Liver Disease Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Chronic alcohol consumption initiates hepatic steatosis (fatty liver),
  with annual mortality rate of 6% (4-7%) and liver-specific mortality of 1% per year'
- 'Step 2: Progressive disease advances through steatohepatitis, characterized by
  inflammation and hepatocyte damage, with annualized progression to cirrhosis of
  10% (6-17%)'
- 'Step 3: Steatohepatitis requiring hospitalization represents the most dangerous
  subtype with 15% annual mortality (8-26% in inpatients)'
- 'Step 4: Development of cirrhosis marks end-stage liver disease with annualized
  mortality of 8% (5-13%), predominantly from liver-specific causes'
- 'Step 5: Cirrhosis leads to liver failure, portal hypertension, hepatocellular carcinoma,
  and other complications directly causing death'
evidence:
  quality_rating: A
  n_studies: 37
  primary_citation: 'Richard Parker et al. 2019. Natural history of histologically
    proven alcohol-related liver disease: A systematic review. Journal of hepatology.'
  supporting_citations: []
description: Alcohol-related liver disease follows a progressive histological pathway
  from steatosis through steatohepatitis and fibrosis to cirrhosis, with each stage
  associated with increasing risk of liver-specific mortality. This systematic review
  of 37 studies with 7,528 participants demonstrates that even early-stage steatosis
  carries significant mortality risk (6%/year), while advanced stages show markedly
  higher death rates. Steatohepatitis requiring hospitalization represents the most
  lethal subtype at 15% annual mortality. The progression rates confirm that alcohol-related
  steatosis is not benign and that liver disease mortality increases as histological
  damage advances.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 8.0
    type: annualized_mortality_rate_percent
    ci_lower: 5.0
    ci_upper: 13.0
  p_value: null
  sample_size: 7528
moderators:
- name: Disease stage
  direction: strengthens
  strength: strong
  description: 'Mortality increases with disease progression: steatosis (6%/year)
    < cirrhosis (8%/year) < steatohepatitis requiring hospitalization (15%/year)'
- name: Hospitalization status
  direction: strengthens
  strength: strong
  description: Inpatient steatohepatitis cohorts had 3x higher mortality (15%) compared
    to mixed inpatient/outpatient cohorts (5%)
- name: Disease subtype
  direction: strengthens
  strength: moderate
  description: Only in steatosis did non-liver-related mortality exceed liver-specific
    mortality; at all other stages liver disease drives mortality
